Chemical companies Quaker Chemical and Houghton International have agreed to divest certain products and related assets to a subsidiary of French multinational corporation Total, to settle Federal Trade Commission (FTC) charges that Quaker’s proposed US$1.4 billion acquisition of Houghton would violate federal antitrust law.
The FTC’s complaint alleges that the proposed acquisition would harm competition in the North American market for aluminum hot rolling oil, or AHRO, and associated technical support services, and in the North American market for steel cold rolling oil, or SCRO, and associated technical support services. According to the complaint, the SCRO market includes sheet cold rolling oil, tin plate rolling oil, or TPRO, and pickle oil. AHRO, SCRO, TPRO, and pickle oil are critical inputs in the production of sheet metal.
The complaint alleges the proposed transaction may substantially lessen competition in the markets for SCRO, AHRO, and their associated technical support services. Quaker and Houghton are the only two commercial suppliers of AHRO in North America and the two largest commercial suppliers of SCRO in North America, according to the complaint.
Full Content: FTC
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas